Tuesday broker round-up UPDATE
12th Jun 2014 08:50
Afren: Oriel downgrades from buy to hold with a target price of 145p. Aggreko: RBC Capital downgrades to neutral with a target price of 1700p. Betfair Group: Morgan Stanley raises target price from 1150p to 1260p and keeps an overweight rating. BG Group: Nomura downgrades to neutral with a target
Read moreCareTech full-year earnings in line as young people unit blooms
5th Dec 2013 08:46
Annual revenues were flat at social care provider CareTech, though earnings increased in line with expectations in an industry that has been battling serious budgetary pressures. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) rose 6% to £26.4m on sales that crawle
Read moreThursday broker round-up UPDATE
5th Dec 2013 08:15
AMEC: Canaccord Genuity raises target price from 1125p to 1300p upgrading from hold to buy. AZ Electronic Materials: Canaccord Genuity increases target price from 354p to 404p, while downgrading from buy to hold. BAE Systems: Deutsche Bank takes target price from 415p to 425p keeping a hold recomm
Read moreCareTech promises in-line results and future cost savings
24th Oct 2013 14:24
AIM-listed care home provider CareTech revealed trading for the full year was in line with expectations. Acquisitions late in the year to September 30th of two properties the company had been renting, are expected to be earnings-enhancing as they will save on "substantial" rental charges of up to £
Read moreWednesday broker round-up UPDATE
2nd Oct 2013 08:02
Advanced Medical Solutions: N+1 Singer shifts target price from 84p to 90p and upgrades from sell to hold. Afren: Nomura lowers target price from 180p to 170p and retains a neutral rating. Aveva: Panmure Gordon raises target price from 2174p to 2374p and keeps a hold recommendation. Barclays: Soc
Read moreFriday broker round-up UPDATE
20th Sep 2013 08:06
African Minerals: Investec reduces target price from 393p to 246p, while its buy recommendation remains unchanged. Ashmore Group: Berenberg cuts target price from 500p to 470p and retains a buy recommendation. ASOS: Deutsche Bank raises target price from 4450p to 4800p and reiterates a hold recomm
Read moreFriday broker round-up UPDATE
13th Sep 2013 08:26
ASOS: Panmure Gordon raises target price from 4555p to 5950p maintaining a buy recommendation. AstraZeneca: Jefferies reduces target price from 3200p to 2850p and retains a hold recommendation. Barclays: Jefferies initiates with a target price of 367p and a buy recommendation. Barratt Development
Read moreCareTech heads buy close to a million shares
28th Aug 2013 15:59
CareTech, the AIM-listed social care services firm, announced Wednesday that both its Executive Chairman and Chief Executive Officer each purchased 485,000 shares. Farouq Sheikh and Haroon Sheikh both paid 190p a share, costing a total of £921,500. The purchases were announced the same day the c
Read moreCareTech saves on rent by buying 29 properties
28th Aug 2013 07:56
CareTech, the AIM-listed social care services firm, is hoping to save substantial costs in rental charges after the acquisition of two property portfolios. The company said on Wednesday that it has bought the freeholds of the portfolios, comprising 29 properties in total, for £38m. "The board res
Read moreThursday broker round-up UPDATE
13th Jun 2013 07:01
African Barrick Gold: Citi moves target price from 175p to 124p and maintains a sell recommendation. ASOS: Nomura raises target price from 2970p to 3400p keeping a neutral rating. Exane increases target price from 4200p to 5000p and retains its outperform rating. Citi ups target price from 4400p to
Read moreFriday tips round-up: CareTech, Premier Farnell and Standard Chartered
7th Dec 2012 07:30
Tempus in The Times writes that one company that has had a difficult couple of years is CareTech Holdings, the AIM-quoted provider of specialist care homes. There was a bizarre row over a policy of capitalising the salaries of members of staff seeking acquisitions. At least one bid and one managem
Read moreRevenue up 4.5 per cent at CareTech
6th Dec 2012 07:11
Revenue rose 4.5 per cent to 114.1m pounds in the year ending September 30th 2012 at CareTech, boosted by underlying pre-tax profit, which climbed 5.0 per cent to 16.7m pounds. Overall capacity at its facilities increase by 110 places to 2,166, while its property portfolio was independently valued
Read moreWeek ahead: BP, Stagecoach, Caretech
30th Nov 2012 17:01
Although December tends to be one of the best months of the year for stocks next week's calendar comes replete with potentially market moving events and at least one potential 'tipping point, ' which markets will need to navigate. George Osborne will present his Autumn Statement on December 5th,
Read moreThursday broker round-up - UPDATE
18th Oct 2012 09:24
Ashtead: UBS raises target from 375p to 400p, buy rating kept. ASOS: Panmure Gordon keeps buy rating and 2,530p target. AZ Electronic Materials: Goldman Sachs upgrades to conviction buy. Booker: Panmure Gordon keeps buy rating and 108p target. Britvic: Panmure Gordon keeps hold rating and 380p t
Read moreCareTech provides positive full-year update
17th Oct 2012 10:39
CareTech has provided a positive trading update for the full year ending September 30th, stating that "trading for the full year will be in line with its expectations". Consensus estimates for the year ended September 30th are for pre-tax profits of £16.74m on turnover of £116.56m. Earlier this ye
Read more